Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02779426 · ClinicalTrials.gov registry record · NA
Texting Atopic Dermatitis Patients to Optimize Learning and EASI Scores
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT02779426 is a NA study that has completed, run by Columbia University. The registered enrollment target is 84 participants.
The verdict
NCT02779426, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if sending text messages with treatment reminders and facts regarding atopic dermatitis (AD) to caretakers of children with AD will have a positive effect on the disease severity.
Interventions
- BEHAVIORAL Text messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02779426
The ClinicalTrials.gov registry entry for NCT02779426 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Text messages is the first listed.
NCT02779426 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02779426 about?
NCT02779426 is a clinical study titled "Texting Atopic Dermatitis Patients to Optimize Learning and EASI Scores". The purpose of this study is to determine if sending text messages with treatment reminders and facts regarding atopic dermatitis (AD) to caretakers of children with AD will have a positive effect on the disease severity.
What is the current status of trial NCT02779426?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2016-05. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02779426?
The interventions under investigation include: Text messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT02779426?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.